Clinical Trials Logo

Ischemic clinical trials

View clinical trials related to Ischemic.

Filter by:

NCT ID: NCT02828488 Active, not recruiting - Clinical trials for Transient Ischemic Attack

Analysis of the Impact of the Fragility of the Over 70 Years of TIAprognosis

AIT70
Start date: August 6, 2015
Phase:
Study type: Observational

Fragility, geriatric concept recent identification is defined by simple physical indicators. The literature suggests that it is related to the risk of hospitalization, falls, institutionalization and death. Some studies have shown a link with heart disease, including heart failure. The link with the TIA (transient ischemic attack) has however never been studied. A fortiori, the impact of the fragility of the risk of recurrent stroke after TIA is unknown. Several questions need to be asked: Among older patients hospitalized for TIA, what proportion of those completing the criteria of frailty? In this same population, is there a correlation between fragility and scores ABCD2 score itself predictive of the risk of subsequent ischemic stroke? In other words, fragile subjects who have a TIA Have a higher risk of ischemic stroke (which could cause a strengthening of prevention measures)?

NCT ID: NCT02643784 Not yet recruiting - Ischemic Clinical Trials

Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke

AIS
Start date: December 2015
Phase: Phase 4
Study type: Interventional

This is an exploratory, randomized, open-label, 2-arm, parallel-group study exploring the efficacy of rosuvastatin (20mg/day) in patients with acute ischemic stroke.

NCT ID: NCT01557842 Terminated - Clinical trials for Ventricular Tachycardia

Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators

ASPIRE
Start date: June 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if early ablation (i.e., ablation of ventricular tachycardia in patients with infrequent VT episodes) is more effective than medical therapy alone for the treatment of ischemic ventricular tachycardia in patients with Implantable Cardioverter Defibrillators (ICDs) who continue to have episodes of ventricular tachycardia despite drug therapy.